| Karen A Shanley, LCSW | |
|
55 Nye Rd, Suite 102, Glastonbury, CT 06033-1281 | |
| (860) 657-3056 | |
| (860) 633-3517 |
| Full Name | Karen A Shanley |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 38 Years |
| Location | 55 Nye Rd, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295763126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CT002447 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Center For Geriatric And Family Psychiatry, Inc. | 8527059955 | 6 |
News Archive
Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.
Organizing this conference is a great honor, and highlights the Center's growing international profile, with the CNIC seeing off competition from an institute in Shanghai. The CNIC's candidature, led by Jos- Luis de la Pompa, was presented in 2011 by the Cardiovascular Development and Repair Department, and enjoyed institutional backing from important Spanish bodies including the Madrid regional government and the Spanish Society of Developmental Biology.
While current American Heart Association heart failure prevention guidelines warn against habitual coffee consumption, some studies propose a protective benefit, and still others find no association at all. Amidst this conflicting information, research from Beth Israel Deaconess Medical Center attempts to shift the conversation from a definitive yes or no, to a question of how much.
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
› Verified 8 days ago
| Entity Name | The Center For Geriatric And Family Psychiatry, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831134766 PECOS PAC ID: 8527059955 Enrollment ID: O20040524000236 |
News Archive
Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.
Organizing this conference is a great honor, and highlights the Center's growing international profile, with the CNIC seeing off competition from an institute in Shanghai. The CNIC's candidature, led by Jos- Luis de la Pompa, was presented in 2011 by the Cardiovascular Development and Repair Department, and enjoyed institutional backing from important Spanish bodies including the Madrid regional government and the Spanish Society of Developmental Biology.
While current American Heart Association heart failure prevention guidelines warn against habitual coffee consumption, some studies propose a protective benefit, and still others find no association at all. Amidst this conflicting information, research from Beth Israel Deaconess Medical Center attempts to shift the conversation from a definitive yes or no, to a question of how much.
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen A Shanley, LCSW 55 Nye Rd, Suite 102, Glastonbury, CT 06033-1281 Ph: (860) 657-3056 | Karen A Shanley, LCSW 55 Nye Rd, Suite 102, Glastonbury, CT 06033-1281 Ph: (860) 657-3056 |
News Archive
Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse.
Organizing this conference is a great honor, and highlights the Center's growing international profile, with the CNIC seeing off competition from an institute in Shanghai. The CNIC's candidature, led by Jos- Luis de la Pompa, was presented in 2011 by the Cardiovascular Development and Repair Department, and enjoyed institutional backing from important Spanish bodies including the Madrid regional government and the Spanish Society of Developmental Biology.
While current American Heart Association heart failure prevention guidelines warn against habitual coffee consumption, some studies propose a protective benefit, and still others find no association at all. Amidst this conflicting information, research from Beth Israel Deaconess Medical Center attempts to shift the conversation from a definitive yes or no, to a question of how much.
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
› Verified 8 days ago
Mrs. Adrianna Olga Zambrzycka-broomhead, LCSW, BCBA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2300 Main St, Glastonbury, CT 06033 Phone: 860-430-1762 | |
Susan Gargiulo, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Hebron Ave, Suite 217, Glastonbury, CT 06033 Phone: 860-659-2697 | |
Anne T Harders, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 55 Nye Rd, Suite 102, Glastonbury, CT 06033 Phone: 860-657-3056 Fax: 860-633-3517 | |
Mrs. Robin S Levine, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19 Carter Ln, Glastonbury, CT 06033 Phone: 860-633-2580 | |
Erin Egan, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 131 New London Tpke, Ste 319, Glastonbury, CT 06033 Phone: 860-617-4378 | |
Penny Rearick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 78 Eastern Blvd, Glastonbury, CT 06033 Phone: 860-794-9490 | |
Ms. Doris Irene Laplante, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 377 Hubbard St, Glastonbury, CT 06033 Phone: 860-604-2490 |